Cystaran (cysteamine 0.44% ophthalmic solution) — Medica

Initial criteria

• Patient has corneal cystine crystal deposits confirmed by slit-lamp examination
• Agent is prescribed by or in consultation with an ophthalmologist or a metabolic disease specialist (or specialist who focuses in the treatment of metabolic diseases)

Approval duration

1 year